CreditReports.dk
HomeScreen companies

Specialty Pharma ApS Financials, key figures and credit report

CVR number: 38476599 Established 2017 Industry: 70 Activities of head offices and management consultancy
Company contact details
Parcelvej 11, 2840 Holte uhs@specialtypharma.dk tel: 21127210 www.specialtypharma.dk
Gross profit 216.7 kDKK FY 2025 +124.8% vs 2024
EBIT -70.7 kDKK FY 2025 -16.6% vs 2024
Net debt -57.5 kDKK FY 2025 -10.3% vs 2024
Quick ratio 0.8 FY 2025 -0.5 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit639.301 023.44292.6996.40216.74
Employee benefit expenses- 704.77- 963.49- 183.75- 157.05- 287.47
EBIT-65.4759.94108.94-60.66-70.74
Other financial expenses-0.50-1.70-2.49-0.36
Pre-tax profit-65.9758.24108.94-63.14-71.10
Income taxes21.74-17.12-28.259.3812.53
Net earnings-44.2341.1380.69-53.76-58.57

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables18.82128.2596.136.39
Current deferred tax assets21.742.629.3821.92
Short term receivables total21.7421.44128.25105.5128.31
Other current investments18.0018.0018.00
Cash and bank deposits101.8594.3434.0734.1839.53
Cash and cash equivalents101.8594.3452.0752.1857.53
Balance sheet total (assets)123.59115.78180.33157.6985.83

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital50.0050.0050.0050.0050.00
Retained earnings-33.08-77.31-36.1844.51-9.25
Profit of the financial year-44.2341.1380.69-53.76-58.57
Shareholders equity total-27.3113.8294.5140.75-17.82
Non-current liabilities total
Short-term deferred tax liabilities25.63
Other non-interest bearing current liabilities150.90101.9660.19116.94103.65
Current liabilities total150.90101.9685.82116.94103.65
Balance sheet total (liabilities)123.59115.78180.33157.6985.83
Page generated